Home › Ductal Carcinoma In Situ (DCIS) › Pennsylvania
Ductal Carcinoma In Situ (DCIS) clinical trials in Pennsylvania
4 studies for Ductal Carcinoma In Situ (DCIS) are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
- UPMC Magee Womens Hospital, Pittsburgh
RecruitingPhase 1
Ages 18 and older · Women · Updated Aug 18, 2026 · NCT06218303The PREDICT Registry:
- St Luke's University Health Network, Easton
- Sidney Kimmel Comprehensive Cancer Ctr - Jefferson, Philadelphia
- AHN Allegheny General Hospital, Pittsburgh
RecruitingObservational study
Ages 30 to 85 · Women · Updated Apr 17, 2026 · NCT03448926EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
RecruitingObservational study
Ages 18 and older · Women · Updated Mar 17, 2026 · NCT07478016Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
- Thomas Jefferson University Hospital, Philadelphia
Recruiting
Ages 40 and older · All sexes · Updated Jan 23, 2026 · NCT04959474From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.